Eterna Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Eterna Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Eterna Therapeutics Inc
Rating: 1.76466675
Author: Trendlyne DVM scores

about

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluri...

1.26 0.04 (3.28%)

54.18% Fall from 52W High

54,066

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.2 / 100

Technically Neutral

58.4 / 100

No estimates available

Eterna Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Eterna Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluri...

54.18% Fall from 52W High

SWOT Analysis

Eterna Therapeutics Inc Live Price Chart